This study highlights one benefit of the integrated health system specialty pharmacy model for patients who are prescribed acalabrutinib.
Kendra R. Delibert, PHARMD, BCOP
Advertisement
Articles by Kendra R. Delibert, PHARMD, BCOP
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
Axatilimab: A New Frontier for Steroid-Refractory Chronic GVHD
2
CHEST 2025: Exploring the Link Between GLP-1 Receptor Agonists, Type 2 Diabetes, and Asthma Risk
3
Immunization and Vigilance: Preventing Infections in T-Cell Modifying Therapies
4
E4 Did Not Significantly Impact Blood Pressure in Postmenopausal Women Receiving Treatment for VMS
5
